hotspot -WSS

hotspot

author：Wikipedia 2025-10-02 13:01:20 - browse：392

Pfizer on Friday said it was stopping development of a twice-daily oral obesity medication after an underwhelming clinical trial, a blow to the company’s efforts to compete in the booming field of weight-loss medications.

The medicine, danuglipron, met its primary target in a placebo-controlled Phase 2b trial, leading to a statistically significant amount of weight lost, the company said. But the weight reductions were smaller than those seen in trials of rival medicines targeting the same GLP-1 pathway, and a high rate of patients experienced side effects and dropped out of the trial.

Pfizer said it would not move twice-daily danuglipron into Phase 3 trials, but that instead it would focus on a once-daily formulation, which is currently undergoing pharmacokinetic studies. Data are expected in the first half of 2024.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Study: Pain burden is higher in Black NFL players than white ones

Wikipedia

WSS

Biden announces an advanced cancer research initiative

Beach reads and more: STAT's 2023 summer book list

Dozens of Pride flags vandalized at Stonewall monument in NYC, 3rd time this month: Police

Lecanemab for Alzheimer's is coming. Is the health system ready?

Biden launches a new push to limit health care costs

Charles Manson follower Leslie Van Houten released from prison after 53 years

hotspot

hotspot

hotspot

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Trader Joe's recalls 10K cases of broccoli cheddar soup over potential foreign material

Drug repurposing or repositioning? The language matters

Why 40% Americans with Parkinson’s don’t see a neurologist

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

CDC: Cases of alpha

DIEP, the 'gold standard' of breast reconstruction, is under threat

NIH fellows want a pay raise. Will that mean less money for grants?

In Memoriam: Notable people who died in 2023

HCA discloses massive data breach affecting 11 million patients

leisure time

Hospitals, health systems can help patients avoid medical debt

Iowa House, Senate pass 6

Biden to sign 'historic' executive order on how US military handles sexual assault cases

American Airlines has a tentative contract deal with its pilots. Southwest is still negotiating

Biden launches a new push to limit health care costs

Alexander Hamilton and the argument for universal insurance

hotspot

entertainment

Wikipedia

focus